Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
42
Views
12
CrossRef citations to date
0
Altmetric
Original Research

S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma

Ken Katono1 Department of Respiratory Medicine, School of Medicine
,
Yuichi Sato2 Department of Molecular Diagnostics, School of Allied Health SciencesCorrespondence[email protected]
,
Makoto Kobayashi3 Department of Applied Tumor Pathology, Graduate School of Medical Sciences
,
Ryo Nagashio2 Department of Molecular Diagnostics, School of Allied Health Sciences
,
Shinichiro Ryuge1 Department of Respiratory Medicine, School of Medicine
,
Satoshi Igawa1 Department of Respiratory Medicine, School of Medicine
,
Masaaki Ichinoe4 Department of Pathology, School of Medicine, Kitasato University, Minami-ku, Sagamihara, Kanagawa, Japan
,
Yoshiki Murakumo4 Department of Pathology, School of Medicine, Kitasato University, Minami-ku, Sagamihara, Kanagawa, Japan
,
Makoto Saegusa4 Department of Pathology, School of Medicine, Kitasato University, Minami-ku, Sagamihara, Kanagawa, Japan
&
Noriyuki Masuda1 Department of Respiratory Medicine, School of Medicine
 show all
Pages 5273-5279 | Published online: 02 Nov 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chanjuan Wang, Xi Zhu, Aiwei Li, Shuo Yang, Rui Qiao & Jie Zhang. (2019) S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway. Cancer Management and Research 11, pages 2449-2456.
Read now

Articles from other publishers (11)

Chaohui Wu, Jiansheng Yang, Xianbin Lin, Rongbin Li & Jingyang Wu. (2023) miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells. The American Journal of the Medical Sciences 365:6, pages 520-531.
Crossref
Yadong Guo, Zongtai Zheng, Shiyu Mao, Fuhan Yang, Ruiliang Wang, Hong Wang, Ji Liu, Cheng Li, Qinwan Wang, Wentao Zhang, Xudong Yao & Shenghua Liu. (2022) Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer. Molecular Carcinogenesis 62:2, pages 185-199.
Crossref
Ting Li, Tianyi Ren, Chumei Huang, Yufang Li, Pengfei Yang, Gang Che, Lisi Luo, Yutong Chen, Siqi Peng, Yujing Lin & Linjuan Zeng. (2021) S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine. Biochemical Pharmacology 189, pages 114396.
Crossref
Jie Zhu, Min Wang & Daixing Hu. (2020) Identification of Prognostic Immune-Related Genes by Integrating mRNA Expression and Methylation in Lung Adenocarcinoma. International Journal of Genomics 2020, pages 1-20.
Crossref
Huifang Lv, Honglin Hou, Huijun Lei, Caiyun Nie, Beibei Chen, Liangyu Bie, Lili Han & Xiaobing Chen. (2020) MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28:3, pages 225-236.
Crossref
Wen-Juan Tian, Shan-Shan Liu & Bu-Rong Li. (2020) The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment 19, pages 153303382097750.
Crossref
A.A. Akhmedova, E.M. Frantsiyants, I.A. Goroshinskaya, V.V. Pozdnyakova, A.I. Shikhlyarova, Yu.A. Pogorelova, I.V. Neskubina, N.D. Cheryarina, O.V. Khokhlova & E.P. Lysenko. (2019) STUDY OF TUMOR-ASSOCIATED MARKERS AND SOME BIOCHEMICAL INDICATORS IN MELANOCYTIC SKIN FORMATIONS. Ulyanovsk Medico-biological Journal:2, pages 80-88.
Crossref
Yang Bai, Liang-Dong Li, Jun Li & Xin Lu. (2018) Prognostic values of S100 family members in ovarian cancer patients. BMC Cancer 18:1.
Crossref
De Chen, Linjie Luo & Chao Liang. (2018) Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma. PLOS ONE 13:5, pages e0197402.
Crossref
Makoto Kobayashi, Ryo Nagashio, Keita Saito, Clemente Aguilar-Bonavides, Shinichiro Ryuge, Ken Katono, Satoshi Igawa, Benio Tsuchiya, Shi-Xu Jiang, Masaaki Ichinoe, Yoshiki Murakumo, Makoto Saegusa, Yukitoshi Satoh & Yuichi Sato. (2018) Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma. Human Pathology 74, pages 148-155.
Crossref
Yuichi Sato, Ryo Nagashio, Kengo Yanagita, Daisuke Hagiuda, Yuki Kuchitsu & Wataru Inoue. (2017) Application of markers obtained by various proteomic methods to resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy. Electrophoresis Letters 61:2, pages 128-131.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.